Regulation of the hyperosmotic induction of aquaporin 5 and VEGF in retinal pigment epithelial cells: Involvement of NFAT5

Molecular Vision

Volumn 21, Issue , 2015, Pages 360-377

  Hollborn, Margrit ^a   Vogler, Stefanie ^a   Reichenbach, Andreas ^a   Wiedemann, Peter ^a   Bringmann, Andreas ^a   Kohen, Leon ^a,b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HELIOS Klinikum Aue   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 5; HYPOXIA INDUCIBLE FACTOR 1; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NFAT5 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR NFAT; TRANSFER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; AQP5 PROTEIN, HUMAN; AQUAPORIN; AQUAPORIN 8; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAPK1 PROTEIN, HUMAN; NFAT5 PROTEIN, HUMAN; SMALL INTERFERING RNA; SODIUM CHLORIDE; SUCROSE; TRANSCRIPTION FACTOR; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AQUAPORIN 5 GENE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPEROSMOTIC STRESS; MOLECULAR DYNAMICS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VEGF GENE; WESTERN BLOTTING; AGONISTS; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; OSMOLARITY; PHOSPHORYLATION; PRIMARY CELL CULTURE; RETINAL PIGMENT EPITHELIUM; SECRETION (PROCESS);

AQUAPORIN 5; AQUAPORINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; OSMOLAR CONCENTRATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PRIMARY CELL CULTURE; RETINAL PIGMENT EPITHELIUM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SODIUM CHLORIDE; SUCROSE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927625167     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Wong TY, Mitchell P. The eye in hypertension. Lancet 2007; 369:425-35. [PMID: 17276782].
2. Kostraba JN, Klein R, Dorman JS, Becker DJ, Drash AL, Maser RE, Orchard TJ. The epidemiology ofdiabetescomplications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 1991; 133:381-91. [PMID: 1994702].
3. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study ofDiabetic Retinopathy: XVII. The 14-year incidence and progression ofdiabetic retinopathyand associated risk factors intype 1 diabetes. Ophthalmology 1998; 105:1801-15. [PMID: 9787347].
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317:703-13. [PMID: 9732337].
5. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321:412-9. [PMID: 10938049].
6. Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000; 118:351-8. [PMID: 10721957].
7. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003; 110:1273-80. [PMID: 12799274].
8. Van Leeuwen R, Tomany SC, Wang JJ, Klein R, Mitchell P, Hofman A, Klein BE, Vingerling JR, Cumming RG, de Jong PT. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology 2004; 111:1169-75. [PMID: 15177967].
9. Suzuma I, Hata Y, Clermont A, Pokras F, Rook SL, Suzuma K, Feener EP, Aiello LP. Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 2001; 50:444-54. [PMID: 11272159].
10. Seko Y, Seko Y, Fujikura H, Pang J, Tokoro T, Shimokawa H. Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro. Invest Ophthalmol Vis Sci 1999; 40:3287-91. [PMID: 10586955].
11. Miller JW, Le Couter J, Strauss EC, Ferrara N. Vascular endothelial growth factor A in intraocular vascular disease. Ophthalmology 2013; 120:106-14. [PMID: 23031671].
12. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-56. [PMID: 11239411].
13. Khaw KT, Barrett-Connor E. The association between blood pressure, age and dietary sodium and potassium: a population study. Circulation 1988; 77:53-61. [PMID: 3257173].
14. Qin Y, Xu G, Fan J, Witt RE, Da C. High-salt loading exacerbates increased retinal content of aquaporins AQP1 and AQP4 in rats with diabetic retinopathy. Exp Eye Res 2009; 89:741-7. [PMID: 19596320].
15. Kawasaka K, Yanagida T, Yamamoto S, Yonemura D. Decrease of electrooculographic potential under osmotic stress in man. Jpn J Ophthalmol 1977; 31:23-8.
16. Steinberg RH, Linsenmeier RA, Griff ER. Retinal pigment epithelial cell contributions to the electroretinogram and electrooculogram. Prog Retinal Res 1985; 4:33-66.
17. Shirao Y, Steinberg RH. Mechanisms of effects of small hyperosmotic gradients on the chick RPE. Invest Ophthalmol Vis Sci 1987; 28:2015-25. [PMID: 3679749].
18. Winkler BS. Hyperosmolarity and electroretinogram (ERG) potentials in isolated rat retinas: possible implications in diabetic models. Exp Eye Res 2003; 77:115-6. [PMID: 12823995].
19. Gilcrease MZ, Hoover RL. Neutrophil adhesion to endothelium following hyperosmolar insult. Diabetes Res 1991; 16:149-57. [PMID: 1802480].
20. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol 2001; 158:147-52. [PMID: 11141487].
21. Orgül S, Reuter U, Kain HL. Osmotic stress in an in vitro model of the outer blood-retinal barrier. Ger J Ophthalmol 1993; 2:436-43. [PMID: 8312831].
22. Millay RH, Klein ML, Shults WT, Dahlborg SA, Neuwelt EA. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol 1986; 102:626-32. [PMID: 3096140].
23. Bresnick GH. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 1983; 90:1301-17. [PMID: 6664669].
24. Bressler NM, Bressler SB, Fine SL. 2001. Neovascular (exudative) age-related macular degeneration. In: Schachat AP (ed) Retina. Mosby, St Louis, 2001; 1100–35.
25. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85:845-81. [PMID: 15987797].
26. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. Müller cells in the healthy and diseased retina. Prog Retin Eye Res 2006; 25:397-424. [PMID: 16839797].
27. Stamer WD, Bok D, Hu J, Jaffe GJ, McKay BS. Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. Invest Ophthalmol Vis Sci 2003; 44:2803-8. [PMID: 12766090].
28. Nagelhus EA, Mathiisen TM, Ottersen OP. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with Kir4.1. Neuroscience 2004; 129:905-13. [PMID: 15561407].
29. Bringmann A, Reichenbach A, Wiedemann P. Pathomechanisms of cystoid macular edema. Ophthalmic Res 2004; 36:241-9. [PMID: 15583429].
30. Verkman AS, Ruiz-Ederra J, Levin MH. Functions of aquaporins in the eye. Prog Retin Eye Res 2008; 27:420-33. [PMID: 18501660].
31. Hollborn M, Rehak M, Iandiev I, Pannicke T, Ulbricht E, Reichenbach A, Wiedemann P, Bringmann A, Kohen L. Transcriptional regulation of aquaporins in the ischemic rat retina: upregulation of aquaporin-9. Curr Eye Res 2012; 37:524-31. [PMID: 22577771].
32. Molinas SM, Trumper L, Marinelli RA. Mitochondrial aquaporin-8 in renal proximal tubule cells: evidence for a role in the response to metabolic acidosis. Am J Physiol Renal Physiol 2012; 303:F458-66. [PMID: 22622463].
33. Calamita G, Ferri D, Gena P, Liquori GE, Cavalier A, Thomas D, Svelto M. The inner mitochondrial membrane has aquaporin-8 water channels and is highly permeable to water. J Biol Chem 2005; 280:17149-53. [PMID: 15749715].
34. Ma T, Fukuda N, Song Y, Matthay MA, Verkman AS. Lung fluid transport in aquaporin-5 knockout mice. J Clin Invest 2000; 105:93-100. [PMID: 10619865].
35. Pedersen PS, Braunstein TH, Jørgensen A, Larsen PL, Holstein-Rathlou NH, Frederiksen O. Stimulation of aquaporin-5 and transepithelial water permeability in human airway epithelium by hyperosmotic stress. Pflugers Arch 2007; 453:777-85. [PMID: 17043812].
36. Zhang YW, Bi LT, Hou SP, Zhao XL, Song YL, Ma TH. Reduced lung water transport rate associated with downregulation of aquaporin-1 and aquaporin-5 in aged mice. Clin Exp Pharmacol Physiol 2009; 36:734-8. [PMID: 19215235].
37. Woo SK, Lee SD, Kwon HM. TonEBP transcriptional activator in the cellular response to increased osmolality. Pflugers Arch 2002; 444:579-85. [PMID: 12194010].
38. Ho SN. The role of NFAT5/TonEBP in establishing an optimal intracellular environment. Arch Biochem Biophys 2003; 413:151-7. [PMID: 12729611].
39. Chen R, Hollborn M, Grosche A, Reichenbach A, Wiedemann P, Bringmann A, Kohen L. Effects of the vegetable polyphenols EGCG, luteolin, apigenin, myricetin, quercetin, and cyanidin in retinal pigment epithelial cells. Mol Vis 2014; 20:242-58. [PMID: 24623967].
40. Fraser-Bell S, Kaines A, Hykin PG. Update on treatments for diabetic macular edema. Curr Opin Ophthalmol 2008; 19:185-9. [PMID: 18408491].
41. Matsuda S, Gomi F, Oshima Y, Tohyama M, Tano Y. Vascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stress. Invest Ophthalmol Vis Sci 2005; 46:1062-8. [PMID: 15728566].
42. Arsenijevic T, Vujovic A, Libert F, Op de Beeck A, Hébrant A, Janssens S, Grégoire F, Lefort A, Bolaky N, Perret J, Caspers L, Willermain F, Delporte C. Hyperosmotic stress induces cell cycle arrest in retinal pigmented epithelial cells. Cell Death Dis 2013; 4:e662-[PMID: 23744362].
43. Hollborn M, Ulbricht E, Reichenbach A, Wiedemann P, Bringmann A, Kohen L. Transcriptional regulation of aquaporin-3 in human retinal pigment epithelial cells. Mol Biol Rep 2012; 39:7949-56. [PMID: 22535323].
44. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 1998; 392:405-8. [PMID: 9537326].
45. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16:4604-13. [PMID: 8756616].
46. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002; 21:2000-8. [PMID: 11960372].
47. Lee K, Lee JH, Boovanahalli SK, Jin Y, Lee M, Jin X, Kim JH, Hong YS, Lee JJ. (Aryloxyacetylamino)benzoic acid analogues: a new class of hypoxia-inducible factor-1 inhibitors. J Med Chem 2007; 50:1675-84. [PMID: 17328532].
48. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M, Cohen A, Gazit A, Levitzki A, Roifman CM. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996; 379:645-8. [PMID: 8628398].
49. Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006; 13:1235-42. [PMID: 17114005].
50. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci USA 1996; 93:9090-5. [PMID: 8799159].
51. Zhao H, Tian W, Cohen DM. Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCδ-independent fashion. Am J Physiol Renal Physiol 2002; 282:F710-7. [PMID: 11880333].
52. Tran TL, Bek T, Holm L, La Cour M, Nielsen S, Prause JU, Rojek A, Hamann S, Heegaard S. Aquaporins 6–12 in the human eye. Acta Ophthalmol (Copenh) 2013; 91:557-63. [PMID: 22974000].
53. Kawedia JD, Yang F, Sartor MA, Gozal D, Czyzyk-Krzeska M, Menon AG. Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways. PLoS ONE 2013; 8:e57541-[PMID: 23469202].
54. Richard DE, Berra E, Gothié E, Roux D, Pouysségur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol Chem 1999; 274:32631-7. [PMID: 10551817].
55. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21:3995-4004. [PMID: 11359907].
56. Zhou B, Ann DK, Li X, Kim KJ, Lin H, Minoo P, Crandall ED, Borok Z. Hypertonic induction of aquaporin-5: novel role of hypoxia-inducible factor-1α. Am J Physiol Cell Physiol 2007; 292:C1280-90. [PMID: 17108010].
57. Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finley J, Thompson HW, Bazan NG. Coordinate activation of HIF-1 and NF-κB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest Ophthalmol Vis Sci 2003; 44:4163-70. [PMID: 14507857].
58. Towne JE, Krane CM, Bachurski CJ, Menon AG. Tumor necrosis factor-α inhibits aquaporin 5 expression in mouse lung epithelial cells. J Biol Chem 2001; 276:18657-64. [PMID: 11279049].
59. Yao C, Purwanti N, Karabasil MR, Azlina A, Javkhlan P, Hasegawa T, Akamatsu T, Hosoi T, Ozawa K, Hosoi K. Potential down-regulation of salivary gland AQP5 by LPS via cross-coupling of NF-κB and p-c-Jun/c-Fos. Am J Pathol 2010; 177:724-34.
60. Molinas SM, Trumper L, Marinelli RA. Mitochondrial aquaporin-8 in renal proximal tubule cells: evidence for a role in the response to metabolic acidosis. Am J Physiol Renal Physiol 2012; 303:F458-66. [PMID: 22622463]. [PMID: 20522648].
61. Funaki H, Yamamoto T, Koyama Y, Kondo D, Yaoita E, Kawasaki K, Kobayashi H, Sawaguchi S, Abe H, Kihara I. Localization and expression of AQP5 in cornea, serous salivary glands, and pulmonary epithelial cells. Am J Physiol 1998; 275:C1151-7. [PMID: 9755069].
62. Levin MH, Verkman AS. Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva. Invest Ophthalmol Vis Sci 2004; 45:4423-32. [PMID: 15557451].
63. Hoffert JD, Leitch V, Agre P, King LS. Hypertonic induction ofaquaporin-5expression through an ERK-dependent pathway. J Biol Chem 2000; 275:9070-7. [PMID: 10722758].
64. Sears JE, Hoppe G. Triamcinolone acetonide destabilizes VEGF mRNA in Müller cells under continuous cobalt stimulation. Invest Ophthalmol Vis Sci 2005; 46:4336-41. [PMID: 16249516].